2022
Nonadherence to Multimodality Cancer Treatment Guidelines in the United States
Tchelebi LT, Shen B, Wang M, Potters L, Herman J, Boffa D, Segel JE, Park HS, Zaorsky NG. Nonadherence to Multimodality Cancer Treatment Guidelines in the United States. Advances In Radiation Oncology 2022, 7: 100938. PMID: 35469182, PMCID: PMC9034283, DOI: 10.1016/j.adro.2022.100938.Peer-Reviewed Original ResearchGuideline-concordant treatmentAnal cancerMultimodality treatmentRectal cancerCervical cancerLung cancerAdvanced non-small cell lung cancerNasopharynx cancerNon-small cell lung cancerNonmetastatic anal cancerNational Cancer DatabasePercent of patientsAdvanced cervical cancerCancer treatment guidelinesCell lung cancerMultivariable logistic regressionPrimary tumor siteLow-volume facilitiesTreatment guidelinesComorbid conditionsCancer DatabaseOdds ratioNational guidelinesPatientsConfounding variables
2018
Permanent Interstitial Brachytherapy for Previously Irradiated Head and Neck Cancer
Breen W, Kelly J, Park HS, Son Y, Sasaki C, Wilson L, Decker R, Husain ZA. Permanent Interstitial Brachytherapy for Previously Irradiated Head and Neck Cancer. Cureus 2018, 10: e2517. PMID: 29942720, PMCID: PMC6015992, DOI: 10.7759/cureus.2517.Peer-Reviewed Original ResearchNeck cancerExtranodal extensionOverall survivalLocal controlAdverse events grade 3Worse locoregional controlCommon Terminology CriteriaPercent of patientsDisease-free intervalSecond primary cancerImprovement of symptomsRecords of patientsWorse local controlWorse overall survivalPermanent interstitial brachytherapyMucosal recurrenceNeck recurrenceTerminology CriteriaLocoregional controlMedian dosePersistent tumorNeck diseasePrimary cancerRecurrent cancerMucosal disease